Impact Biomedical IBO
NYSE IBO
$4.02 +0.22 (+5.78%)
As of: Oct 23, 2026 · 1:02 PM EDT

Impact Biomedical (IBO) Net Debt Issuances and Repayments (2022 - 2026)

Updated

Analysis

Impact Biomedical (IBO) Net Debt Issuances and Repayments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,133.17 Bn 1,101.76 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 634.79 Bn 554.65 Bn 17.30 Bn -4.36 Bn
3 AbbVie 506.40 Bn 479.51 Bn 12.70 Bn -2.00 Bn
4 Merck 357.93 Bn 312.31 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 292.69 Bn 256.68 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 265.19 Bn 238.87 Bn 12.86 Bn -2.46 Bn
7 Amgen 238.22 Bn 193.61 Bn 7.24 Bn -
8 Gilead Sciences 195.23 Bn 169.43 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn 64.00 Mn
10 Impact Biomedical 433.42 Mn 433.37 Mn 2,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 481,000.00
Dec 31, 2024 317,000.00
Sep 30, 2024 -60,000.00
Jun 30, 2024 384,000.00
Mar 31, 2024 483,000.00
Dec 31, 2023 232,000.00
Sep 30, 2023 870,000.00
Jun 30, 2023 746,000.00
Mar 31, 2023 1.02 Mn
Dec 31, 2022 539,000.00
Sep 30, 2022 773,000.00
API Access

Impact Biomedical Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=IBO&period=max&api_key=YOUR_API_KEY